StockData
RELX PLC logo

RELX PLC (RELX) KPIs and segments

RELXNYSEServices-Business Services, NECFiscal year ends December 31Also trades as RLXXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 19, 2026Score 8/30
$39.39−1.05 (-2.60%)

Close on Nov 17, 2026Market cap $71.65BP/E 26.6Yield –

KPI & bộ phận

Chỉ số vận hành và bộ phận làm nên hoạt động của RELX · năm tài chính kết thúc ngày 31 tháng 12

Nhìn nhanh KPI của RELX: 63 chỉ số vận hành, trong đó có Subscription Revenue, Transactional Revenue và Electronic Format Revenue, lấy từ 407 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.

Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.

Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.

Thêm vào biểu đồChỉ số
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Subscription Revenue
2,633.002,625.002,565.002,534.002,491.002,521.00
Transactional Revenue (Including Long-Term Volumetric Contracts)
2,238.002,224.002,176.002,259.002,150.002,141.00
Electronic Format Revenue1
Electronic Share of Group Revenue
86.00
Face-to-Face Format Revenue1
Face-to-Face Share of Group Revenue
11.00
Print & Print-Related Format Revenue
157.00210.00189.00278.00239.00
Group Underlying Revenue Growth (YTD / Annual)4
7.007.007.007.007.007.007.007.008.00
Risk Underlying Revenue Growth
8.008.008.008.008.008.008.008.008.00
Scientific, Technical & Medical (STM) Underlying Revenue Growth
6.006.005.005.005.004.004.004.004.00
Legal Underlying Revenue Growth
10.0010.009.009.009.007.007.007.006.00
Exhibitions Underlying Revenue Growth
4.006.008.008.008.0011.0013.0016.0030.00
Group Underlying Adjusted Operating Profit Growth (Semi-Annual / Annual)5
9.009.009.0010.0010.0013.00
Risk Underlying Adjusted Operating Profit Growth
10.0010.009.009.009.009.00
STM Underlying Adjusted Operating Profit Growth
8.007.007.005.005.004.00
Legal Underlying Adjusted Operating Profit Growth
13.0012.0011.009.008.008.00
Exhibitions Underlying Adjusted Operating Profit Growth
2.009.009.0031.00100.00
Constant-Currency Adjusted EPS Growth
11.0010.0010.009.0010.0011.00
Risk — Adjusted Operating Profit1
697.00645.00660.00612.00621.00
Risk — Adjusted Operating Margin
38.5037.4037.80
Risk — Revenue (Semi-Annual & Restated Annual)
1,810.001,737.001,748.001,669.001,667.00
Scientific, Technical & Medical (STM) — Adjusted Operating Profit1
519.00544.00491.00509.00472.00
STM — Adjusted Operating Margin
37.9038.1037.10
STM — Revenue (Semi-Annual & Restated Annual)
1,370.001,391.001,323.001,342.001,282.00
Legal — Adjusted Operating Profit1
208.00227.00188.00206.00175.00
Legal — Adjusted Operating Margin
21.7023.0020.90
Legal — Revenue (Semi-Annual & Restated Annual)
959.00906.00900.00866.00852.00
Exhibitions (RX) — Adjusted Operating Profit1
226.00176.00234.00175.00223.00146.00
Exhibitions — Adjusted Operating Margin
39.3034.6040.30
Exhibitions (RX) — Revenue (Semi-Annual & Annual)
575.00605.00581.00638.00601.00570.00
Print & Print-Related Activities — Adjusted Operating Profit
78.00101.0084.00
Annual Technology Spend1
Capitalized Internally Developed Intangible Expenditure
280.00261.00243.00
Ordinary Shares in Issue (Excluding Treasury Shares) / Total Voting Rights1
85,329,583.0073,295,338.001,793,214,976.001,823,940,375.001,827,473,522.001,836,733,684.001,850,784,115.001,861,224,342.001,864,172,709.001,868,205,136.001,879,623,404.001,887,195,412.00
Ordinary Shares Held in Treasury
85,329,583.0073,295,338.0035,163,923.004,107,872.0054,981,300.0045,110,268.0030,808,431.0019,607,670.0045,080,324.0040,296,743.0028,616,185.0019,712,193.00
Ordinary Shares Repurchased (Monthly / Quarterly Period Split)1
12,034,245.0038,131,415.0031,056,051.0010,418,832.0013,799,232.0011,703,366.003,381,458.004,929,469.0011,364,912.009,219,638.00
Ordinary Shares Repurchased (Cumulative Calendar Year-to-Date)
81,221,711.0069,187,466.0031,056,051.0035,921,430.0025,502,598.0011,703,366.0028,895,477.0025,514,019.0020,584,550.009,219,638.0030,912,126.00
Share Repurchases Deployed
1,750.00500.001,000.00300.00700.00250.00
Ordinary Dividend Per Share (Sterling)2
20.9048.0019.5044.8018.2041.80
Ordinary Dividend Per Share (Euro Equivalent)
0.240.550.230.530.210.49
Ordinary Dividends Paid (Cash Outflow)
851.00357.00824.00
Net Debt (Including Lease Liabilities & Derivatives)2
8,733.007,201.007,443.006,563.006,973.006,446.00
Net Debt / Adjusted EBITDA Leverage(×)
2.302.002.201.802.002.00
Acquisitions — Total Consideration
103.008.00262.00134.0061.0019.00
Peer Reference — S&P Global Inc. (SPGI) Revenue4
3,678.004,146.004,171.005,219.003,443.003,755.003,777.003,592.003,575.003,549.003,491.003,152.00
Moody's Corporation (MCO) Revenue
2,023.002,185.002,079.001,889.002,007.001,898.001,924.001,672.001,813.001,817.001,786.001,480.00
Verisk Analytics, Inc. (VRSK) Revenue
809.00806.00783.00779.00768.00773.00753.00736.00725.00717.00704.00677.00
MSCI Inc. (MSCI) Revenue
892.00867.00851.00823.00793.00773.00746.00744.00725.00708.00680.00690.00
Gartner, Inc. (IT) Revenue
1,676.001,511.001,753.001,524.001,686.001,534.001,715.001,484.001,595.001,473.001,586.00
Consolidated Revenue3
4,871.004,849.004,741.004,793.004,641.004,662.00
North America Revenue (Customer Market)
2,878.002,758.002,837.002,743.002,752.002,685.00
Europe Revenue (Customer Market)
1,018.001,044.00956.001,067.00958.00997.00
Rest of World Revenue (Customer Market)
975.001,047.00948.00983.00931.00980.00
Adjusted Operating Profit4
1,727.001,690.001,652.001,616.001,583.001,544.00
Adjusted Operating Margin
35.5034.8034.8034.10
Adjusted EBITDA
1,992.001,938.001,908.001,883.001,841.001,808.00
Adjusted EBITDA Margin
40.9040.1040.20
Adjusted Earnings Per Share
68.6065.0063.5060.6059.5057.80
Adjusted Cash Flow3
1,691.001,649.001,652.001,603.001,498.001,554.00
Adjusted Cash Flow Conversion Rate
98.00100.0095.00
Free Cash Flow Before Dividends
1,163.001,167.001,146.00
Capital Expenditure (PPE & Internally Developed Intangibles)
292.00270.00255.00251.00233.00

In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).

Phương pháp và các chỉ số bị loại
  • Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
  • RELX PLC is a UK-domiciled Foreign Private Issuer reporting in pounds sterling (GBP) under IFRS with a December 31 fiscal year-end. It files annual reports on Form 20-F, six-month interim financial statements (H1 ended June 30) on Form 6-K, Q1 (April) and 9M (October) trading updates on Form 6-K, and monthly Total Voting Rights and share buyback notices on Form 6-K.
  • Beginning in FY2025 (with comparative restatements for FY2023 and FY2024), RELX reports remaining print and print-related activities separately from its four core business areas (Risk, Scientific, Technical & Medical, Legal, and Exhibitions) and transferred a small commercial healthcare portfolio from STM to Risk.
  • For semi-annual IFRS and Adjusted flow metrics disclosed in H1 (Q2) and Full-Year (Q4) results without standalone quarterly income statements, H1 is mapped to Q2 and H2 is derived on Q4 via period subtraction (full year minus first half year-to-date).
  • Parent-only subtraction (consolidated minus standalone parent) is not applicable because RELX PLC standalone is a non-trading investment holding company with zero third-party operating revenue; instead, self-disclosed audited statutory figures from RELX's four primary UK operating subsidiaries are presented directly.

Không hiện vì thiếu các kỳ gần đây (5)

  • Bounded point-in-time platform scale figures in Annual Reports and Investor Seminars (such as >4.2m / >4.6m Elsevier article submissions, >795,000 / >800,000 published articles, >2.9bn article views/downloads, >3,000 journals, >37,000 editors, >1.9m peer reviewers, >20m monthly ScienceDirect researchers, >5m Lexis+ AI prompts in the US, >511m US consumer credit assessments, and >7,500 government agencies) — excluded from active rows because RELX discloses them with Inequality bounds ('over' / 'more than' / '>') rather than exact point series.
  • OECD/UNESCO/BMI global R&D expenditure ($1.9T–$3.0T actuals for 2015–2024, 2025e–2026f estimates), global researcher counts (7.9M–11.8M actuals for 2015–2024), and global practicing nurses & physicians (32.5M–42.4M actuals for 2015–2023) from the November 2026 STM Investor Seminar — excluded from active rows because FY2025 figures are projections/estimates rather than completed historical actuals.
  • LexisNexis Risk Solutions UK Limited average employee headcount (350 in FY2022, 450 in FY2023, 676 in FY2025) — excluded from active rows because the FY2024 comparative headcount column was omitted in the scanned UK statutory note, leaving a 1-year gap prior to FY2025.
  • Qualitative full-year guidance ('another year of strong underlying growth in revenue and adjusted operating profit, as well as strong growth in adjusted earnings per share on a constant currency basis') and Q1 April trading updates — excluded because RELX does not issue numerical guidance ranges or standalone Q1 segment figures.
  • Scope 3 Category 1 & 2 purchased goods and services emissions (272,000 tCO2e in FY2024; 271,000 tCO2e in FY2025) and Category 7 employee commuting estimates (5,900 tCO2e) — excluded as modeled supply-chain extrapolations with only two years of comparable CSRD history, whereas assured 9-year Scope 1, Scope 2, and Cirium EmeraldSky flight series are included.

Dữ liệu cập nhật 2026-11-10.

Mỗi KPI một trang riêng

Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số

Workforce (Full-Time Equivalents), Technology Investment & Staff Costs

Tài liệu nguồn mới nhất

Các tài liệu được trích nhiều nhất cho số liệu mới nhất của RELX

See a number that looks wrong?